FRANKLIN RESOURCES INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 77 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$6,759,026
-18.4%
189,594
+5.6%
0.00%
-25.0%
Q2 2023$8,285,779
+15.1%
179,618
+0.1%
0.00%0.0%
Q1 2023$7,197,629
-14.2%
179,492
-0.9%
0.00%0.0%
Q4 2022$8,389,992
+13.6%
181,092
+1.5%
0.00%0.0%
Q3 2022$7,386,000
-30.9%
178,363
-0.5%
0.00%
-20.0%
Q2 2022$10,691,000
-17.8%
179,1970.0%0.01%0.0%
Q1 2022$13,013,000
-13.6%
179,197
-0.0%
0.01%0.0%
Q4 2021$15,070,000
-17.5%
179,211
-11.5%
0.01%
-28.6%
Q3 2021$18,260,000
-5.4%
202,461
+0.0%
0.01%0.0%
Q2 2021$19,298,000
-16.3%
202,385
-0.0%
0.01%
-22.2%
Q1 2021$23,048,000
-34.5%
202,427
-20.3%
0.01%
-40.0%
Q4 2020$35,172,000
+11.8%
254,078
-33.6%
0.02%0.0%
Q3 2020$31,464,000
-0.8%
382,827
+0.1%
0.02%
-6.2%
Q2 2020$31,726,000
+86.7%
382,4730.0%0.02%
+45.5%
Q1 2020$16,993,000
+7.3%
382,473
+3.2%
0.01%
+37.5%
Q4 2019$15,830,000
+154.4%
370,650
+154.8%
0.01%
+166.7%
Q3 2019$6,222,000
-71.6%
145,450
-32.1%
0.00%
-70.0%
Q2 2015$21,942,000
+64.9%
214,3000.0%0.01%
+66.7%
Q1 2015$13,306,000
+41.5%
214,3000.0%0.01%
+50.0%
Q4 2014$9,403,000
-24.8%
214,300
-2.9%
0.00%
-33.3%
Q3 2014$12,497,000
+14.5%
220,800
-9.2%
0.01%
+20.0%
Q2 2014$10,913,000
-8.2%
243,1000.0%0.01%
-16.7%
Q1 2014$11,885,000243,1000.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2014
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 519,119$40,605,0003.00%
First Light Asset Management, LLC 236,958$18,535,0002.16%
SECTOR GAMMA AS 108,734$8,505,0001.76%
Rock Springs Capital Management LP 646,841$50,596,0001.39%
Capital Impact Advisors, LLC 30,582$2,392,0000.80%
Atika Capital Management LLC 79,000$6,180,0000.80%
FEDERATED HERMES, INC. 4,080,359$319,166,0000.79%
Rhenman & Partners Asset Management AB 61,500$4,811,0000.52%
Ikarian Capital, LLC 73,500$5,749,0000.46%
Capital International, Inc./CA/ 477,858$37,378,0000.46%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders